SUBSCRIBE
SUBSCRIBE
News   Deals

IMPAX Laboratories, Inc. Acquires Rights to Abbreviated New Drug Applications From Watson Laboratories, Inc. And Cobalt Laboratories

December 2, 2009 | 
1 min read

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced it acquired Abbreviated New Drug Applications (ANDA) from Watson Pharmaceuticals and Cobalt Laboratories, a subsidiary of Arrow Group.

Mergers & acquisitions Regulatory
MORE ON THIS TOPIC
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Pictured: Regeneron logo on a light brown building
Lymphoma
Regeneron Narrows Approval Aspirations for Lymphoma Bispecific, Citing ‘Competitor Developments’
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong